Francis Willard Sarena Five Prime Therapeutics, Inc. (FPRX) insider trading activity

Francis Willard Sarena is Chief Strategy Officer of FIVE PRIME THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of FPRX, which is worth approximately $0. The most recent transaction as insider was on Apr 16, 2021, when has been sold 169,468 shares (Common Stock) at a price of $38.0 per share, resulting in proceeds of $6,439,784. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Francis Willard Sarena Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 16 2021	SELL Sale (or disposition) back to the issuer	$6,439,784 $38.0 p/Share	169,468 Reduced 100.0%	0 Common Stock
Apr 16 2021	BUY Grant, award, or other acquisition	-	66,000 Added 28.03%	169,468 Common Stock
Apr 06 2021	SELL Bona fide gift	-	14,174 Reduced 12.05%	103,468 Common Stock
Apr 05 2021	SELL Bona fide gift	-	2,460 Reduced 2.05%	117,642 Common Stock
Apr 01 2021	SELL Bona fide gift	-	3,825 Reduced 3.09%	120,102 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$25,742 $22.23 p/Share	1,158 Reduced 0.93%	123,433 Common Stock
Feb 25 2021	SELL Payment of exercise price or tax liability	$38,151 $23.08 p/Share	1,653 Reduced 1.31%	124,591 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$131,121 $25.71 p/Share	5,100 Reduced 3.88%	126,244 Common Stock
Dec 11 2020	SELL Payment of exercise price or tax liability	$186,950 $16.14 p/Share	11,583 Reduced 8.39%	126,427 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	-	22,000 Added 13.75%	138,010 Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$198,018 $18.0 p/Share	11,001 Reduced 8.66%	116,010 Common Stock
Nov 11 2020	BUY Exercise of conversion of derivative security	-	22,000 Added 14.76%	127,011 Common Stock

Also insider at

BCAC

Brookline Capital Acquisition Corp. Financial Services

President and COO

ETNB

89bio, Inc. Healthcare

Chief Operating Officer

FWS